Response to Meurs, Menke-Pluijmers, Seisling, and Westenend
JNCI Cancer Spectr
.
2020 Sep 3;4(6):pkaa080.
doi: 10.1093/jncics/pkaa080.
eCollection 2020 Dec.
Authors
Shi-Yi Wang
1
2
,
Peiyin Hung
3
,
Brigid K Killelea
2
4
,
Sarah S Mougalian
2
5
,
Suzanne B Evans
2
6
,
Cary P Gross
2
7
Affiliations
1
Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
2
Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center, New Haven, CT, USA.
3
Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
4
Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
5
Department of Internal Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
6
Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.
7
Department of Internal Medicine, Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
PMID:
33417658
PMCID:
PMC7771427
DOI:
10.1093/jncics/pkaa080
No abstract available
Grants and funding
UL1 TR001863/TR/NCATS NIH HHS/United States